Listen to leaders in cardiothoracic surgery discuss hot topics in the field. Please note: The comments included in these episodes are that of the individuals involved and not necessarily that of The Society of Thoracic Surgeons.
Episodes
Monday Mar 02, 2020
Monday Mar 02, 2020
Cardiovascular disease is the #1 killer of people around the world, with approximately 18 million deaths annually, according to the World Health Organization. Treatment options for heart disease include lifestyle changes, stenting, and surgery. But which option is best and for which patients? Thomas E. MacGillivray, MD, moderates a panel discussion with Jennifer S. Lawton, MD, John D. Puskas, MD, Marc Ruel, MD, MPH, and Joseph F. Sabik III, MD. They explore recent results from the ISCHEMIA trial, implications for the heart team, and which patients benefit the most from percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), or medical therapy.